MANCONE, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 8.390
EU - Europa 2.833
AS - Asia 1.076
AF - Africa 78
SA - Sud America 59
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 12.445
Nazione #
US - Stati Uniti d'America 8.308
IT - Italia 1.266
IN - India 457
SE - Svezia 398
CN - Cina 304
FI - Finlandia 231
DE - Germania 216
UA - Ucraina 207
SG - Singapore 166
GB - Regno Unito 81
IE - Irlanda 80
PH - Filippine 73
MK - Macedonia 72
BG - Bulgaria 66
CA - Canada 63
RO - Romania 54
TG - Togo 47
FR - Francia 38
AR - Argentina 36
RU - Federazione Russa 35
BE - Belgio 19
KR - Corea 19
NL - Olanda 18
TR - Turchia 16
MY - Malesia 14
BZ - Belize 12
UG - Uganda 11
CO - Colombia 9
ES - Italia 7
GR - Grecia 7
MX - Messico 7
PL - Polonia 7
RS - Serbia 7
AT - Austria 6
CL - Cile 6
EG - Egitto 6
HK - Hong Kong 6
BR - Brasile 5
IR - Iran 5
JP - Giappone 5
PT - Portogallo 5
EU - Europa 4
SC - Seychelles 4
VN - Vietnam 4
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
ID - Indonesia 3
PE - Perù 3
PK - Pakistan 3
ZA - Sudafrica 3
CZ - Repubblica Ceca 2
LV - Lettonia 2
MA - Marocco 2
NG - Nigeria 2
SN - Senegal 2
HU - Ungheria 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SI - Slovenia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.445
Città #
Fairfield 1.373
Chandler 678
Woodbridge 641
Ashburn 629
Seattle 502
Cambridge 480
Rome 468
Wilmington 458
Houston 454
San Paolo di Civitate 277
Princeton 276
Dearborn 240
Ann Arbor 230
Lawrence 182
Beijing 163
Plano 159
Millbury 133
San Diego 122
Boston 118
Helsinki 79
New York 79
Dublin 76
Sofia 66
Des Moines 63
Milan 61
Andover 60
Fremont 50
Jacksonville 49
Lomé 47
Norwalk 39
Boardman 36
Federal 34
Singapore 33
Toronto 33
San Jose 27
Nanjing 22
Bremen 20
Brussels 18
London 18
Ottawa 18
Skopje 18
Hefei 17
Lappeenranta 17
Bühl 16
Latina 16
San Mateo 16
Southend 16
Guidonia Montecelio 15
Quezon City 15
Guangzhou 14
Kunming 14
Portland 14
Bitola 13
Buffalo 13
Phoenix 13
Amsterdam 12
Belize City 12
Falls Church 11
Redwood City 11
Verona 11
Chicago 10
Mykolayiv 10
Dallas 9
Jinan 9
Los Angeles 9
Paris 9
Redmond 9
Bologna 8
Centrale 8
Columbus 8
Frankfurt am Main 8
Imus 7
Nanchang 7
Pune 7
Seongnam 7
Atlanta 6
Davao City 6
Hong Kong 6
Madrid 6
Olongapo City 6
Pasay 6
Ankara 5
Bari 5
Kilburn 5
Mexico City 5
Ohrid 5
Vienna 5
Xian 5
Zagazig 5
Adelfia 4
Binangonan 4
Changsha 4
Chengdu 4
Dasmarinas 4
Formia 4
Frosinone 4
Kampala 4
Kraljevo 4
Loutsa 4
Lviv 4
Totale 9.040
Nome #
CT or invasive coronary angiography in stable chest pain 319
Ezetimibe added to statin therapy after acute coronary syndromes 159
High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART. a meta-analysis 118
Comparison of therapy with ticagrelor, prasugrel or high clopidogrel dose in pci patients with high on treatment platelet reactivity and genotype variation. triplete reset trial 111
Age-related changes in dopamine D2 receptors in rat heart and coronary vessels 103
null 102
Giant right atrium and subvalvular pulmonary stenosis: a case report of an interesting combination 101
Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment 101
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management. results of an EAPCI survey 99
Frequency of naturally-occurring regulatory T cells is reduced in patients with ST-segment elevation myocardial infarction 97
DISTRIBUTION OF ACETYLCHOLINESTERASE AND CHOLINEACETYL-TRANSFERASE ACTIVITIES IN CORONARY VESSELS OF YOUNGER AND OLDER ADULTS 95
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease 95
Diabetes mellitus and ischemic heart disease. the role of ion channels 90
Role of cardiac123I-mIBG imaging in predicting arrhythmic events in stable chronic heart failure patients with an ICD 87
Reply to “Regarding the article of ceccacci et al. (2016; 223: 54–55)” entitled “Role of MIBG scintigraphy in reverse Tako-tsubo cardiomyopathy: confirming a pathophysiologic hypothesis" 85
Prevention of cardiovascular disease. screening for magnesium deficiency 84
Changes in Intraventricular flow patterns after mitraclip Implant in patients with functional severe mitral regurgitation 84
3D echo characterization of proportionate and disproportionate functional mitral regurgitation before and after percutaneous mitral valve repair 84
Correction to: Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain 83
Screening high school students in Italy for sudden cardiac death prevention by using a telecardiology device. a retrospective observational study 81
Mid-term repair durability after MitraClip implantation in patients with functional mitral regurgitation 81
Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients 81
Are Drusen Markers of Impaired Glucose Tolerance? 80
A novel closed-chest porcine model of chronic ischemic heart failure suitable for experimental research in cardiovascular disease 80
Structural and myocardial dysfunction in heart failure beyond ejection fraction 80
Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes. insights from the optical coherence tomography (OCT)-FORMIDABLE registry 77
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry 77
Heart failure and iron deficiency 77
Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention in patient with HIV/HCV coinfection: case report and review of the literature 76
The statin therapy to prevent atrial fibrillation after cardiac surgery. shakespearean dilemma 76
Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection. A scoping review 76
Save the unlucky unrevascularized acute coronary syndrome patient 75
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin. 75
Plasma endothelin-1 levels in patients with resistant hypertension. effects of renal sympathetic denervation 75
Effects of ivabradine on residual myocardial ischemia after PCI evaluated by stress echocardiography 75
Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. 75
Rosuvastatin pre-treatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis. The ROMA trial. 75
Prasugrel or ticagrelor in st-segment-elevation myocardial infarction patients with diabetes mellitus 75
Cardiovascular disease in HIV patients. from bench to bedside and backwards 74
Interventional cardiology: Effectiveness of stents in high-risk and 'real world' patients. 73
Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes. a propensity matched analysis 73
Myocardial ischemia and diabetes mellitus. role of oxidative stress in the connection between cardiac metabolism and coronary blood flow 73
null 73
Heart failure with preserved, mid-range, and reduced ejection fraction. the misleading definition of the new guidelines 73
Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjects 73
Fatal Takotsubo syndrome in critical COVID-19 related pneumonia 73
Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention. 72
Effect of adenosine intracoronary bolus on myonecrosis occurrence in elective PCI (RACE trial) 72
Beneficial Impact of Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation 72
Coronary artery bifurcation narrowing treated by axxess stent implantation. the CARINAX registry 72
Evaluation of coronary features of HIV patients presenting with ACS. the CUORE, a multicenter study 72
Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes 72
Pulmonary Arterial Dilatation in Pulmonary Hypertension: Prevalence and Prognostic Relevance 71
Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study 71
Role of MIBG scintigraphy in reverse tako-tsubo cardiomyopathy: confirming a pathophysiologic hypothesis 71
A multicenter randomized study to evaluate intracoronary abciximab with the ClearWay catheter to improve outcomes with Lysis (IC ClearLy): Trial study design and rationale 71
Triggers for atrial fibrillation. the role of anxiety 70
Acute coronary syndromes and covid-19. exploring the uncertainties 69
Prevalence and predictors of long corrected QT interval in HIV-positive patients. a multicenter study 69
Cardiac involvement in consecutive unselected hospitalized COVID-19 population: in-hospital evaluation and one-year follow-up 69
Effect of coronary percutaneous revascularization on interferon-gamma and interileukin-10 producing CD4(+) T cells during acute myocardial infarction 68
Aspirin-dependent effects on purinergic P2Y1 receptor express 68
Performance of prognostic risk scores in chronic heart failure patients enrolled in the european society of cardiology heart failure long-term registry 68
TNM-like classification: A new proposed method for heart failure staging 67
Safety of FFR-guided revascularisation deferral in Anatomically prognostiC disease (FACE. cardiogroup V study). a prospective multicentre study 67
Troponin I as a specific marker of myocardial injury: from theory to clinical practice in the diagnosis of acute coronary syndrome 67
Correction to. structural and myocardial dysfunction in heart failure beyond ejection fraction (heart failure reviews, (2019), 10.1007/s10741-019-09828-8) 67
Prognostic Indicators for Recurrent Thrombotic Events in HIV-infected Patients with Acute Coronary Syndromes: Use of Registry Data From 12 sites in Europe, South Africa and the United States 67
Value of two-dimensional longitudinal strains analysis to assess the impact of thrombus aspiration during primary percutaneous coronary intervention on left ventricular function: A speckle tracking imaging substudy of the EXPIRA trial 66
Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy. the impact of late referral. 65
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity. the INVESTIG8 registry 65
Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan 65
Long-term outcome after drug-eluting stent implantation in unselected population: ROME and UDINE Experience (The RUDI Registry) 65
AGE-RELATED CHANGES IN CATHECHOLAMINERGIC NERVE FIBERS OF RAT HEART AND CORONARY VESSELS 64
The effect of thrombectomy on myocardial blush in primary angioplasty: the Randomized Evaluation of Thrombus Aspiration by two thrombectomy devices in acute Myocardial Infarction (RETAMI) trial 64
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA heart failure long-term registry 64
Single-staged compared with multi-staged PCI in multivessel NSTEMI patients. the SMILE trial 64
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients. the RUDI-FREE study 63
Cost-effectiveness of Levosimendan in Patients With Acute Heart Failure 63
Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019. an updated perspective of the european experience 61
Impact of Thrombectomy With EXPort Catheter in Infarct-Related Artery During Primary Percutaneous Coronary Intervention (EXPIRA Trial) on Cardiac Death 60
Impact of an optical coherence tomography guided approach in acute coronary syndromes. a propensity matched analysis from the international formidable-cardiogroup IV and USZ registry 60
Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials 60
2D/3D echocardiographic determinants of left ventricular reverse remodelling after mitraclip implantation 60
Culprit plaque characteristics in younger versus older patients with acute coronary syndromes. an optical coherence tomography study from the FORMIDABLE registry 60
Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial 60
Early elevation of interleukin-1β and interleukin-6 levels after bare- or drug-eluting stent implantation in patients with stable angina 60
Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): Safety, tolerability, clinical, and haemodynamic effect 59
Role of ion channels in coronary microcirculation: a review of the literature. 59
Perspectives: How to evaluate healthcare systems in primary angioplasty 59
Rationale and design of a multicenter, international and collaborative coronary artery aneurysm registry (CAAR) 59
The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry 59
Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease. 59
Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial 58
TEST CINECA 58
Heart failure pharmacological management. gaps and current perspectives 57
Heart failure and iron deficiency anemia in Italy: Results from CARMES-1 registry 57
Advanced heart failure and end-stage heart failure. does a difference exist 57
Levosimendan improves renal function in acute decompensated heart failure:possible underlying mechanisms. 56
Sex- and age-related differences in the management and outcomes of chronic heart failure. an analysis of patients from the ESC HFA EORP heart failure long-term registry 56
Totale 7.623
Categoria #
all - tutte 37.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 63
selected - selezionate 0
volume - volumi 0
Totale 37.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019673 0 0 0 0 0 0 0 0 0 0 361 312
2019/20202.634 303 73 57 247 246 388 382 284 244 198 117 95
2020/20211.767 69 109 27 50 360 133 58 112 201 395 174 79
2021/20222.756 58 144 213 128 360 115 70 278 235 173 499 483
2022/20232.817 522 663 142 246 255 277 69 193 250 45 123 32
2023/20241.585 69 218 124 269 269 228 58 130 17 197 6 0
Totale 13.317